title: Chemoimmunotherapy of canine lymphoma with adjuvant canine monoclonal antibody 231.
abstract: Chemoimmunotherapy with adjuvant CL/MAb 231 offers an alternative treatment approach for canine lymphoma. Results of treatment and prognostic factors are discussed and compared with previously published chemotherapy results.
authors.affiliation: Veterinary Oncology Services and Research Center, West Chester, Pennsylvania, USA.
authors.forename: K A
authors.initials: KA
authors.lastname: Jeglum
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D004283:Dog Diseases / Q000628:therapy*; D004285:Dogs; D004358:Drug Therapy / Q000592:standards / Q000662:veterinary; D007167:Immunotherapy / Q000592:standards / Q000662:veterinary*; D008223:Lymphoma / Q000628:therapy / Q000662:veterinary*
chemical_list: D000911:Antibodies, Monoclonal